Buzz

Moderna On Track to Report COVID-19 Vaccine Late-Stage Trial Data in November

This week Moderna “said it is on track to report early data from a late-stage trial of its experimental COVID-19 vaccine next month, reports Reuters, “offering the clearest timeline yet for when the world will know whether it is effective.”

The company, one of the front-runners in the global race to produce vaccines to protect against COVID-19, said an independent data monitoring committee is expected to conduct an interim review of its ongoing 30,000-person trial in November… The company said it is preparing to distribute the vaccine, known as mRNA-1273, and expects to be able to produce 20 million doses by the end of the year, and between 500 million and 1 billion in 2021. Moderna said infection rates in the trial were on track with expectations…

Moderna said it expects two-month follow-up safety data, as required by the U.S. Food and Drug Administration, in the second half of November, after which it will file for an emergency use authorization.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

13 + thirteen =

This site uses Akismet to reduce spam. Learn how your comment data is processed.